American College of Physicians: Internal Medicine — Doctors for Adults ®

Advertisement

MKSAP Quiz: Skin eruption after tick removal

From the June ACP Internist, copyright © 2014 by the American College of Physicians

A 22-year-old man is evaluated for a skin eruption on his leg. The patient lives in Virginia and is active outdoors. One week ago, he found a black tick on his lower leg, which his roommate removed with a tweezers. Yesterday he developed diffuse myalgia, neck stiffness, and fatigue. These symptoms have persisted, and today he notes erythema at the site of the previously attached tick.

On physical examination, temperature is 38.1°C (100.6°F); other vital signs are normal. There is no nuchal rigidity. Skin findings are shown.

Photo © American College of Physicians

Photo © American College of Physicians



Which of the following is the most appropriate initial management?

A: Borrelia burgdorferi polymerase chain reaction on skin biopsy specimen

B: Empiric intravenous ceftriaxone

C: Empiric oral doxycycline

D: Serologic testing for Lyme disease

Answer and critique

The correct answer is C: Empiric oral doxycycline. This question can be found in MKSAP 16 in the Infectious Disease section, item 23.

The skin lesion shown is consistent with erythema migrans, and oral doxycycline should be started immediately. Erythema migrans may be due to either early localized Lyme disease or Southern tick associated rash illness. Although these two infections are caused by specific tick vectors with relatively distinct geographic distributions, both ticks are endemic to Virginia. Geographic location is therefore of little value in differentiating between these two syndromes in this patient. However, empiric doxycycline is the recommended treatment for erythema migrans regardless of the cause. Treatment should be given based on the clinical finding of an expansile, target-like skin lesion, particularly at the site of a known tick attachment.

Borrelia burgdorferi polymerase chain reaction testing is not indicated. Although B. burgdorferi may be amplified from erythema migrans skin biopsy specimens if the diagnosis is uncertain, this study is generally not needed because the presence of the characteristic erythema migrans rash, such as is seen in this patient, dictates treatment.

Intravenous ceftriaxone is reserved for patients with cardiac or neurologic manifestations of disseminated Lyme disease.

Serologic testing for B. burgdorferi is not recommended because false-negative antibody assay results may occur in patients with early localized Lyme disease and would be negative in patients with Southern tick associated rash illness.

Key Point
  • Empiric oral doxycycline is the recommended treatment for erythema migrans regardless of the cause.

Top


.

Subscribe to MKSAP 16

ACP’s MKSAP helps you to:

  • Update your knowledge in all areas of internal medicine
  • Assess your medical knowledge with 1,200 all-new multiple-choice questions
  • Pass the ABIM Certification Exam or the ABIM Recertification Exam
  • Support your clinical decisions in practice

To order the most current edition, go online.

Top

This is a printer-friendly version of this page

Print this page  |  Close the preview

Share

 
 

Internist Archives Quick Links

What will you learn from your Annals Virtual Patient?

Reviews of the World's Top Medical Journals—FREE to ACP Members! Annals Virtual Patients is a unique patient care simulator that mirrors real patient care decisions and consequences. CME Credit and MOC Points are available. Start off with a FREE sample case. Start your journey now.

Products and Resources for Patients

Products and Resources for PatientsACP has developed easy- to-use materials designed to help educate your patients on self-management of a wide variety of common health conditions. Order yours today!